MET Institote of Pharmney

Bhnjbal Knowfedge City. Adgnon, Nashik

Pharmacy Practice Department

CASE STUDY ON: Preuenia

CRse No. :
ABC VPD No.: Date:
16 to|2f
Narne of Patient: Age: urhs Gender:

Height: Weight: BMI:

Address: Marital Status:

Occupation:
Dept./Ward: i )
( Ward No. DOA: DOD:

Chief Complaints:
Complaints Duration Frequency
2elays

Provisional Diagnosis:
freunowia
Final Diagnosis: Pnwwem a

Past Medical History

:eomowY Ly
Past Medication History :

Famiíy History:
Social History:
Alcoholic: Smoker: Tobacco chewer: AnyOther:

Allergies:
Pregnancy:
 Day Day
Vital Sign Day Day Day 3 Day4Day SDay Day
Temp
Pulse /min 12 31 136
BP (mmHg)
RR /min 43 44 43
HR /min
Sp02 %

LABORATORY INVESTIGATIONS REPORTS

CLINICAL HEMATOLOGY: 12o Normal reference range (Units)
Day Day Day Conventional S
Hb Male 13.5-17.5 g/dL 2.09-2.71 mmol/L
WBC
Female:3041dL 12-16 g/dL
4500
1.86-2.48 mmol/L
4.5-11.0 x 10/L
J-31 ML
X(0'| 11,000/mm?
Polymorphs 40-62% 0.54-0.62 L
Lymphocytes 25 -33% 0.25-0.33 L
Eosinophil 12 1-3% 0.01-0.03 L
Monocytes 3.7% 0.03-0.07 L
Basophils <1% <0.01 L
ESR Male
0-20 mm in 1 hr 0-20 mm in 1 hr
Female
Platelets 0-30 mm in 1 hr 0-30 mm in 1 hr

RBC
283 X19/ 150,000
400,000/mm
150-400 x 10°/L
Male
4.3 4.3-5.9 x 1012
5.9x109/mm? Cells/L
Female
3.5 3.5-5.5 x 1012
HCT/PCV Male 5.5x10/mm? Cells/L
41 -53% 0.41-0.53
Female
MCV 36- 46% 0.36-0.46
MCH 80-100 um? 80-100 fl
25.4-34.6 0.39-0.54 fmol/cell
MCHC PB/cell
31- 36% Hb/cell 4.81-5.58 mmol
RDW CV Hb/L
RDW SD 11.5 -15.5 % 11.5 -15.5 %
39-46 fL 39-46 fL
Blood Glucose:
Fasting <100mg/dL
Postprandial <5.6 mmol/L
Random <140mg/dL <7.8 mmol/L
Electrolytes : <200mg/dL 11.2 mmol/L
Sodium
Potassium 135-147m/gL 135-147 mmol/L
Calcium 3.5-5 mLq/L 3.5-5 mmol/L
Phosphate 8.8-10.2 mg/dL 2.2-2.5 mmol/dL
Chloride 2.5-5 mLq/L 2.5-5 mmol/L
95-105 mLa/L 95-105 mmol/L
ipid Profile
TotalCholesterol <200 mg/d. <52 mmol/L
<160 mg/d. e1.80 mmol/L
Triglycerides <130 mg/dL 3.36 mmal/L
LDL >1.16 mmol/L
HDL
>45 mg/dL
0.1 to 1.7 mmol
VLDL 2 to30 mng/dL
Renal Function test: 6-8.3 g/dL 64-83 g/L
Total Protein 20-40 mg/dL 2.5-6.7 mmol/L
Blood Urea 5-51gl4s 0.6-1.2 mg/dL 50-110 mmol/L
52.91 mmol/L
Serum Male 0.74-1.35 mg/dl
Creatinine Female |8-18mg/dL 3-6.5 mmol/L
BUN
Liver functiontest: 0.35 U/L 0-0.58 ukat/L
0-0.58 ukat/
AST-(SGOT) 0-35 U/L
0.5-2.0 ukat/L
ALT-(SGPT) 25-2 30-120 U/L
ALP 0.1-1mg/dL 1.7-17.1 umol/L
Bilirubin Total 0-0.2 mg/dL 0.3-4 umol/L
Direct 0.1-0.8 mg/dL 1.7-13.7 umol/L
Indirect
Blood Group : Sec. (10-12).
Min. (5-9),
Clotting time:
Prothrombin time(PT)
Bleeding time: min. (<5)
Sec. (35-45)
Activated partial thromboplastic time (APTI):05

URINE ANALYSIS : Nil

Urine sugar Ni
Urine albumin Ni
Ketone bodies |-2/hpf
Pus cells (pc) |-2/hpf
Epithelial pus cells (epc) Nil
RBC/Granular cyst Ni
Bile-salts (BS) Ni
Bile pigments (BP)
Direct Billirubin

ysysiSaMorChet fyanned
Other Investigations:

fuud aouation in
elAsolt
 ASSESSMENT PLAN
D D
3D 4D SD
Sr.
Dose Route Frequency D1 D D
Drugs
Anghnin L
2RFwr( Bgrad Bp
3 llinctspM:sw ay
Bp
4:Cei31ne
tte
6Cocb dropue SOS

PHARMACIST INTERVENTION

METS